177 related articles for article (PubMed ID: 1446635)
1. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats.
Sahu A; Sninsky CA; Phelps CP; Dube MG; Kalra PS; Kalra SP
Endocrinology; 1992 Dec; 131(6):2979-85. PubMed ID: 1446635
[TBL] [Abstract][Full Text] [Related]
2. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis.
Sahu A; Dube MG; Phelps CP; Sninsky CA; Kalra PS; Kalra SP
Endocrinology; 1995 Dec; 136(12):5718-24. PubMed ID: 7588328
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y release is elevated from the microdissected paraventricular nucleus of food-deprived rats: an in vitro study.
Dube MG; Sahu A; Kalra PS; Kalra SP
Endocrinology; 1992 Aug; 131(2):684-8. PubMed ID: 1639015
[TBL] [Abstract][Full Text] [Related]
4. Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus.
Bonavera JJ; Dube MG; Kalra PS; Kalra SP
Endocrinology; 1994 Jun; 134(6):2367-70. PubMed ID: 8194462
[TBL] [Abstract][Full Text] [Related]
5. Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes.
Sahu A; Sninsky CA; Kalra SP
Brain Res; 1997 May; 755(2):339-42. PubMed ID: 9175903
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy.
Sahu A; Sninsky CA; Kalra PS; Kalra SP
Endocrinology; 1990 Jan; 126(1):192-8. PubMed ID: 2136723
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y release in the paraventricular nucleus is decreased during transient hyperphagia induced by microinjection of colchicine into the ventromedial nucleus of rats.
Jain MR; Dube MG; Kalra SP; Kalra PS
Neurosci Lett; 1998 Oct; 256(1):21-4. PubMed ID: 9832207
[TBL] [Abstract][Full Text] [Related]
8. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats.
Dube MG; Xu B; Kalra PS; Sninsky CA; Kalra SP
Brain Res; 1999 Jan; 816(1):38-46. PubMed ID: 9878684
[TBL] [Abstract][Full Text] [Related]
9. Involvement of neuropeptide Y in glucose sensing in the dorsal hypothalamus of streptozotocin diabetic rats - in vitro and in vivo studies of transmitter release.
Gozali M; Pavia JM; Morris MJ
Diabetologia; 2002 Sep; 45(9):1332-9. PubMed ID: 12242467
[TBL] [Abstract][Full Text] [Related]
10. The hypothalamic paraventricular nucleus is not essential for orexigenic NPY or anorexigenic melanocortin action.
Dube MG; Kalra SP; Kalra PS
Peptides; 2006 Sep; 27(9):2239-48. PubMed ID: 16759748
[TBL] [Abstract][Full Text] [Related]
11. Effect of d-fenfluramine on neuropeptide Y concentration and release in the paraventricular nucleus of food-deprived rats.
Dube MG; Sahu A; Phelps CP; Kalra PS; Kalra SP
Brain Res Bull; 1992 Dec; 29(6):865-9. PubMed ID: 1473018
[TBL] [Abstract][Full Text] [Related]
12. Testosterone raises neuropeptide-Y concentration in selected hypothalamic sites and in vitro release from the medial basal hypothalamus of castrated male rats.
Sahu A; Kalra SP; Crowley WR; Kalra PS
Endocrinology; 1989 Jan; 124(1):410-4. PubMed ID: 2909374
[TBL] [Abstract][Full Text] [Related]
13. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats.
White JD; Olchovsky D; Kershaw M; Berelowitz M
Endocrinology; 1990 Feb; 126(2):765-72. PubMed ID: 2404748
[TBL] [Abstract][Full Text] [Related]
14. Role of ghrelin in streptozotocin-induced diabetic hyperphagia.
Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
Endocrinology; 2002 Dec; 143(12):4934-7. PubMed ID: 12446621
[TBL] [Abstract][Full Text] [Related]
15. Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.
Taksande BG; Kotagale NR; Nakhate KT; Mali PD; Kokare DM; Hirani K; Subhedar NK; Chopde CT; Ugale RR
Br J Pharmacol; 2011 Sep; 164(2b):704-18. PubMed ID: 21564088
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of diabetic hyperphagia in neuropeptide Y--deficient mice.
Sindelar DK; Mystkowski P; Marsh DJ; Palmiter RD; Schwartz MW
Diabetes; 2002 Mar; 51(3):778-83. PubMed ID: 11872679
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of neuropeptide Y and its mRNA in STZ-diabetic rats.
Fu M; Li X; Zhang M; Xian Y
Chin Med J (Engl); 2002 May; 115(5):690-5. PubMed ID: 12133536
[TBL] [Abstract][Full Text] [Related]
18. Increased endogenous noradrenaline and neuropeptide Y release from the hypothalamus of streptozotocin diabetic rats.
Morris MJ; Pavia JM
Brain Res; 2004 Apr; 1006(1):100-6. PubMed ID: 15047028
[TBL] [Abstract][Full Text] [Related]
19. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine.
Dryden S; Frankish HM; Wang Q; Williams G
Brain Res; 1996 Jun; 724(2):232-7. PubMed ID: 8828573
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y loses its orexigenic effect in rats with lesions of the hypothalamic paraventricular nucleus.
Wang J; Yuan Z; Dong J; Zhang D; Usami T; Murata T; Narita K; Higuchi T
Endocr Res; 2013; 38(1):8-14. PubMed ID: 22594946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
